Literature DB >> 10029276

Rat gastrointestinal motor responses mediated via activation of neurokinin receptors.

F Y Chang1, S D Lee, G H Yeh, P S Wang.   

Abstract

Natural neurokinins (NK) and their specific receptor agonists, including substance P (SP), neurokinin A (NKA), neurokinin B (NKB), septide, [NIe10]-NKA4-10 and senktide, were used to assess whether they could activate established NK receptors in rat gastrointestinal tract and central nervous system to alter gastric emptying or intestinal transit. Fasting rats were intubated with an orogastric catheter to feed them liquid radiochromium. Neurokinins and analogues (at 10(-10), 10(-9), 10(-8) and 10(-7) mol/kg) and vehicle (saline + 0.1% bovine serum albumin) were injected via an intraperitoneal route. Rats were killed 15 min later and the whole gut was removed. The radioactivity of the stomach and 10 equally divided small intestinal segments was counted to determine gastric emptying and the geometric centre of intestinal transit. Septide treatment at 10(-8) and 10(-7) mol/kg markedly delayed gastric emptying. All doses of NKA inhibited gastric emptying. However, other peptides did not influence gastric emptying. Both septide and NKB treatment at 10(-8) and 10(-7) mol/kg enhanced intestinal transit. Substance P or senktide treatment (10-(-7) mol/kg) also enhanced intestinal transit. Stasis of remaining radioactivity in the proximal intestine was found following SP, septide, NKA and NKB treatment, whereas accelerated transit in the distal intestine was induced following NKA, NKB and senktide treatment. In conclusion, the in vivo study of NK and their specific agonists manifests a selective influence of these compounds on rat gastrointestinal tract. This selective activation of stomach NK1 and NK2 receptors delays gastric emptying, whereas activation of intestinal NK1 and NK3 receptors enhances intestinal transit.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10029276     DOI: 10.1046/j.1440-1746.1999.01808.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Regional variations in neurokinin receptor subtype contributions to muscularis mucosae and epithelial function in rat colon.

Authors:  Caroline B Appleyard; Marangelie Morales; William H Percy
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

2.  Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders.

Authors:  Pankaj J Pasricha; Katherine P Yates; Irene Sarosiek; Richard W McCallum; Thomas L Abell; Kenneth L Koch; Linda Anh B Nguyen; William J Snape; William L Hasler; John O Clarke; Sameer Dhalla; Ellen M Stein; Linda A Lee; Laura A Miriel; Mark L Van Natta; Madhusudan Grover; Gianrico Farrugia; James Tonascia; Frank A Hamilton; Henry P Parkman
Journal:  Gastroenterology       Date:  2017-10-28       Impact factor: 22.682

Review 3.  Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Authors:  Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

Review 4.  Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.

Authors:  Alessandro Lecci; Angela Capriati; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

5.  The role of cholecystokinin 1 receptor in prolactin inhibited gastric emptying of male rat.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen; Paulus S Wang
Journal:  J Neurogastroenterol Motil       Date:  2012-10-09       Impact factor: 4.924

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.